
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Step by step instructions to Pick A Pre-owned vehicle Stage - 2
Bismuth’s haredi draft bill won’t change enlistment, IDI expert tells 'Post' - 3
7 Fun Plans to Make Film Evenings Seriously Energizing (You'll Cherish #5!) - 4
'I carried my wife's body for an hour and a half' - BBC hears stories of protesters killed in Iran - 5
What's going around right now? COVID, flu, stomach bug on the rise
The hunt for dark matter: a trivia quiz
The Reduced Portage Horse: An Inheritance Reconsidered for Present day Experience
6 Shades Brands For Seniors
CDC clarifies stance on vaccines and autism, stating no evidence supports the link
Behind every perfect holiday memory is a mom on the brink
Warnings rise for U.S. as severe flu strain causes outbreaks in Canada, U.K.
Figure out How to Upgrade Your Gold Speculation Portfolio: Vital Bits of knowledge and Strategies
The 15 Most Powerful Forerunners in Business
Planet-eating stars hint at Earth's ultimate fate












